S-TEST CYP 125MG/ML MDV IN ETHYL OLEATE OIL, Rx Only, 10ml glass vial, Red Mountain Compounding Rx.
Published November 13, 2019 · Recall initiated: August 12, 2019
Summary
FDA records drug Class II recall D-0281-2020, published November 13, 2019 and initiated August 12, 2019. Recalling firm: First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy; Status: Terminated; Reported quantity: 2x10ml glass vial; Lot: Lot #: S03152019JL@03, Exp 9/15/19. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy
- Distributor
- Nationwide in the USA
- Lot
- Lot #: S03152019JL@03, Exp 9/15/19;
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAMETHYLCOBALAMIN 10,000MCG/ML MDV INJ, Rx only, Red Mountain Compounding RxNovember 3, 2021
- FDATEST CYP 50MG/ML IN ETHYL OLEATE OIL, Rx only, Red Mountain Compounding RxNovember 3, 2021
- FDADEXPANTHENOL 250MG/ML INJ SOLN, Rx only, Red Mountain Compounding RxNovember 3, 2021
- FDAPYRIDOXINE HCL (B6) 100MG/ML MDV, Red Mountain Compounding RxNovember 3, 2021
- FDAS-MICB12C/Cartinine 25/50/50/1/50MG/ML MDV INJ, Rx Only, 30ml, Red Mountain Compounding Rx.November 13, 2019
- FDAS-TEST CYP/NAN-DECA 200/50MG/ML MDV IN SESAME OIL; Rx Only, 10ml glass vial. Red Mountain Compounding RxNovember 13, 2019
Questions about this recall
Was S-TEST CYP 125MG/ML MDV IN ETHYL OLEATE OIL, Rx Only, 10ml glass vial, Red Mountain Compounding Rx. recalled?
Yes. FDA published recall D-0281-2020 on November 13, 2019. Reported hazard: Lack of Assurance of Sterility
What should I do if I have this product?
Voluntary: Firm initiated · Letter